Genesys is a science-focused technology platform whose sole objective is to advance the discovery of human therapeutics. It was designed to optimize the entire drug discovery process; from target identification and elimination to in-silico forced degradation and dissolution modeling. The strategic objectives for Genesys were to:

• Enhance Discovery Performance
• Optimize Research Risk Management
• Increase Execution Success
• Mitigate Research Risk Costs

The Genesys Drug In-Silico Discovery Optimization Platform was written exclusively to leverage the enormous potential of the Intel® Itanium 2® processor and its Explicitly Parallel Instruction Computing (EPIC™) architecture. Microsoft® technologies were utilized for construction including Windows Server for Itanium™, SQL Server™, C# as the primary development environment and F# for sophisticated scripting and sequencing between program components and dynamic resource allocation and optimization.

Read the Genesys Fact Sheet for additional information.